| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.099 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |